How to buy Assembly Biosciences stock (ASMB)

Assembly Biosciences is a biotechnology business based in the US. Assembly Biosciences shares (ASMB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $13.51 – a decrease of 11.99% over the previous week. Assembly Biosciences employs 65 staff and has a trailing 12-month revenue of around $21.5 million.

Our top picks for where to buy Assembly Biosciences stock

Buy Assembly Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Assembly Biosciences stock price (NASDAQ: ASMB)

Use our graph to track the performance of ASMB stocks over time.

Assembly Biosciences shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$13.51
52-week range	$9.12 - $19.93
50-day moving average more info button	$16.40
200-day moving average more info button	$14.99
Wall St. target price	$35.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-6.89

Is it a good time to buy Assembly Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Assembly Biosciences price performance over time

Historical closes compared with the close of $14.28 from 2024-12-17

1 week (2024-12-12)	-6.97%
1 month (2024-11-19)	-6.91%
3 months (2024-09-19)	-22.81%
6 months (2024-06-18)	-4.03%

1 year (2023-12-19)	1,778.95%
2 years (2022-12-19)	-11.19%
3 years (2021-12-17)	27
5 years (2019-12-19)	248.4

Assembly Biosciences financials

Revenue TTM	$21.5 million
Gross profit TTM	$-63,895,000
Return on assets TTM	-34.72%
Return on equity TTM	-101.78%
Profit margin	-212.33%
Book value	$7.50
Market Capitalization more info button	$85.9 million

TTM: trailing 12 months

Assembly Biosciences share dividends

We're not expecting Assembly Biosciences to pay a dividend over the next 12 months.

Have Assembly Biosciences's shares ever split?

Assembly Biosciences's shares were split on a 1:12 basis on 11 February 2024 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Assembly Biosciences shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Assembly Biosciences shares which in turn could have impacted Assembly Biosciences's share price.

Assembly Biosciences share price volatility

Over the last 12 months, Assembly Biosciences's shares have ranged in value from as little as $9.1212 up to $19.93. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Assembly Biosciences's is 0.588. This would suggest that Assembly Biosciences's shares are less volatile than average (for this exchange).

Assembly Biosciences overview

Assembly Biosciences, Inc. , a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd.

Frequently asked questions

null
What percentage of Assembly Biosciences is owned by insiders or institutions?
Currently 31.618% of Assembly Biosciences shares are held by insiders and 18.792% by institutions. How many people work for Assembly Biosciences?
Latest data suggests 65 work at Assembly Biosciences. When does the fiscal year end for Assembly Biosciences?
Assembly Biosciences's fiscal year ends in December. Where is Assembly Biosciences based?
Assembly Biosciences's address is: Two Tower Place, South San Francisco, CA, United States, 94080 What is Assembly Biosciences's ISIN number?
Assembly Biosciences's international securities identification number is: US9228221019 What is Assembly Biosciences's CUSIP number?
Assembly Biosciences's Committee on Uniform Securities Identification Procedures number is: 045396108